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Results Discussion
Similar to other published reports, the primary finding of our study is 
that a multimodal approach to the insertion and care of central venous 
catheters will result in significant reduction in rates of CLABSI. However, our 
study is different in several important ways from previous investigations. Other 
3 6
From 2004 to 2011 the rate of CLABSI declined significantly from 5.86 to 0.6 infections per 1000 catheter days (p<0.0001).  
There was a significant consistent downward trend (0.4 fold decrease per year) in the rate of infections (p<0.0001) (Figure 1).  
The number of catheterizations differed significantly by type, with approximately eight times as many CVCs being performed 
than peripherally inserted central catheters (PICCs) (p<0 0001) From 2008 to 2009 catheter usage significantly increased (p=0 0009)
Abstract # 583
Introduction: CLABSI remains a significant problem in the intensive care unit.  Hypothesis: A multimodal 
approach for the insertion and care of central lines will  prevent central line associated bloodstream infections 
(CLABSI).  Methods: A Critical Care Operations Committee was formed to transform care in eight intensive 
care units (ICU) in an academic medical center in 9/2004. One goal was to reduce CLABSI. Using evidence 
based medicine, a clinical practice guideline was developed that incorporated the use of maximum barrier 
precautions, chlorhexidine skin preparation, avoidance of the femoral insertion site, dedicated catheter cart, a 
check list, tracking high risk central venous catheters (CVC), anti-septic or antimicrobial impregnated 
catheters, a recommendation to use ultrasound guidance when inserting a CVC in the internal jugular vein, 
daily determination of a need for the CVC and treatment of CLABSI as a critical event CLABSI were
Introduction
investigations included a single ICU that did not use antiseptic catheters , or 
were collaborative cohort studies which included a large number of different 
ICUs (community hospitals versus tertiary medical centers)7. In addition to the 
elements of the Pronovost study7, we included use of chlorhexidine sponges 
and antibiotic impregnated catheters. The time period in our study is also the 
longest for studies of this type.
The neuro-trauma unit has one of the highest CLABSI rates in the 
medical center yet has one of the lowest APACHE III scores. The lower 
APACHE III score likely reflects the fact that stroke patients are also admitted 
to this unit, which would “dilute” the acuity of the patient population. Since the 
protocol as to how we care for these catheters does not change from unit to 
unit, it is surprising that the rates are as high as they are in the neuro-trauma 
      . .           .  
whereas from 2010 to 2011 it dropped significantly (p=0.0015). However, the number of PICCs did not significantly change in frequency 
over time (Figure 2).  Table 3 shows the longest CLABSI-free time and APACHE III scores for individual units. Microbiology data are 
presented in Table 4.
Central venous catheters are essential for the care of the critically ill 
patient. However, serious complications can occur with their use. One such 
li ti i t l li i t d bl d t i f ti (CLABSI) Alth h th
               .   
adjudicated by the hospital epidemiologist and CVC days were tracked.  Rates of CLABSI were followed from 
9/2004 through 7/2011. The Spearman correlation coefficient was used for statistical evaluation. A p<0.05 was 
considered significant. Results: CLABSI rates (per 1000 catheter days) declined dramatically from 2004 to 
2011 (p<0.05): 2004: 5.86; 2005: 3.46; 2006: 3.74; 2007: 2.89; 2008: 1.34; 2009: 1.12; 2010: 0.84; 2011 
(annualized): 0.49. One ICU has not had a CLABSI for over 3 years.  Conclusions: A multimodal approach to 
CVC insertion and care reduces CLABSI by over 90%.  Our ultimate goal is the complete eradication of 
CRLASI in our institution.
TABLE 1:  Key Milestones and Interventions
Year Milestone and Intervention
2004 CCOC started 9/13
2005 • Bloodstream Infection (BSI) clinical practice guideline (CPG) 
program recommendations made to the CCOC 2/16
• Standardize education on central venous catheter (CVC) 
insertions.
• Use of maximum barrier precautions during CVC insertions
• Use of chlorhexidine skin prep
unit and the Medical 2 ICU particularly since similar units have a much lower 
rate. We do not have a ready explanation for this finding.
Our CVC utilization rate peaked in 2010 and decreased in 2011. 
This observation is most likely the result of better adherence to catheter 
removal when indicated and to an increasing reliance on PICCs.
In summary, use of a multimodal approach to catheter care resulted 
in over an 89% decrease in CLABSI over a 7-year period. 
comp ca on s cen ra  ne assoc a e  oo s ream n ec on . oug  e 
attributable mortality associated with these infections is likely not affected, the 
economic costs and morbidity can be substantial. 
In 2000, the estimated number of CLABSI in intensive care units (ICU) in 
the United States per year was 80,000. Since that time, both behavioral and 
technological interventions have resulted in reduced CLABSI rates.  For example, 
an estimated 25,000 fewer CLABSI occurred in 2009 in US ICUs than occurred in 
20011. Hand hygiene, education programs2-4 and use of maximum barrier 
precautions5, catheter bundles6 and check lists7 are some of the behavioral changes 
that have resulted in reductions in CLABSI. Technological advances include 
aqueous or alcoholic chlorhexidine solutions for skin preparation8, 9, chlorhexidine 
patches for catheter site care10 and antiseptic or antibiotic impregnated 
Figure 1
• Use of chlorhexidine sponge for dressing
• Empower nurses to monitor catheter placement and stop the 
procedure when deemed appropriate
• Complete a quality assurance (QA) checklist during CVC insertion
• Documentation of insertion via a standardized procedure note
• Assess need for central or arterial catheters on a daily basis
• Avoid femoral catheters whenever possible; the preferred site is 
the subclavian vein
2006 • BSI CPG approved
• E‐learning module active 4/4
• Quality rounds focus on CLABSI
2007 • Standardized use of antibiotic or antiseptic catheters in catheter 
cart 2/28
• Tracking of high risk catheters by location, placement and 
Methods
In 2004, a critical care operations committee (CCOC) was formed at 
UMass Memorial Medical Center with the intent on providing standardized care to 
our critically ill patients by developing clinical practice guidelines based on the best 
catheters11,12.
Although these aforementioned studies showed significant reductions in 
CLABSI, the rates remain relatively high. In this study we describe our approach 
toward reducing CLABSI rates in the intensive care units at UMass Memorial 
Medical Center, Worcester, MA.
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duration 5/07
• Positive blood cultures reviewed by eICU LIP staff daily 9/07
2008 • BSI eLearning module activated for MDs, residents, affiliate 
practitioners and fellows 4/08
• UMMMC begins public reporting of CLABSIs to the Mass DPH 
7/08
• eICU BSI tool developed 4/08
• Critical event analysis for each CLABSI 4/08
• Atlas of pictures on standardized central line dressing 8/08
• Interventional radiology implemented PICC improvement 
process 
2009 • Reporting of blood culture contamination rates at the CCOC 
1/09
• Implement a reporting system on staff completion of eLearning 
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the necessary supplies, catheter insertion using maximum barrier precautions, pre-
procedural time out, use of a check list during catheter insertion, empowering the 
bedside nurse to stop the procedure if elements in the checklist were not followed, 
incorporation of chlorhexidine solutions for skin preparation and chlorhexidine 
sponges for catheter dressings, tracking of high risk catheters (i.e. those were 
inserted during emergencies or in the femoral vein), treating a CLABSI as a critical 
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training program 3/09
• Use of only minocycline/rifampin (MR) catheters 6/09
• Transparent occlusive dressing with chlorhexidine (CHG) 
replaces CHG sponge dressing
2010 • CPG initiated in the Emergency Department (ED) 9/10
• Quality rounds in the ED 10/10
• ED procedure note revised 12/10
2011 • MR catheters used in ED 2/3
• BSI bundle compliance may be obtained via electronic 
procedure note 4/21
TABLE 3:  CLABSI‐Free Time and APACHE III Scores
Unit Current 12 month 
rolling mean 
CLABSI rate 
(events/1000 
catheter‐days)
Longest time free of 
CLABSI (Days)
Second quarter 2011 
APACHE III score
Neuro‐Trauma 1.0 381 53.7
General and Transplant 0.4 334 66.2
Cardiothoracic 0.4 729 52.5
Medical 1 0.6 329 69.9
Medical 2 1.1 329 68.8
Pediatric 0.0 1432 N/A
Medical/Surgical 0.0 788 53.8
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(Table 2). A panel of physicians that was led by the hospital epidemiologist 
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website
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TABLE  2:  Definitions of CLABSI
Criterion 1 Patient has a recognized pathogen cultured from one or 
more blood cultures and the cultured organism is not 
related to an infection at another site
Criterion 2 Patient has at least one of the following signs or symptoms: 
fever (>38oC), chills or hypotension; and signs and 
symptoms and positive laboratory results are not related to 
an infection at another site; and common skin commensal 
is cultured from two or more blood cultures drawn on 
separate occasions
TABLE 4:  Microbiology of CLABSI
Pathogen 2004 2005 2006 2007 2008 2009 2010 2011
Coagulase Negative Staph aureus √ √ √ √ √ √ √ √
Staph aureus √ √ √ √ √
Methicillin‐Resistant Staph aureus √ √ √ √ √
Enterococcus √ √ √ √ √ √ √
Vancomycin Resistant Enterococcus √ √ √ √ √ √
Candida species √ √ √ √ √ √ √ √
Serratia marcescens √
Pseudomonas aeruginosa √ √ √
Klebsiella pneumoniae √ √
e ca   . .
.
The number of catheterizations was modeled using general linear models 
with first and second order slopes fit for each type of catheter type to detect linear 
trends and changes to those trends.  Differences in infection rates were evaluated 
with a Poisson test.  The trend in catheter blood infection rates was modeled using 
Poisson regression.
The distributional assumptions of methods used were evaluated using the 
Kolmorov-Smirnov goodness of fit test for normality and by visual inspection of 
frequency histograms, both performed on residuals from models fit to the 
appropriate design.  Poisson regression was performed using LogXact.  Linear 
models were fit using the Mixed procedure (SAS).
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Criterion 3 Patient < 1 year of age has at least one of the following 
signs: fever (>38oC  core), hypothermia (<36oC core), apnea 
or bradycardia; and the signs and symptoms and positive 
laboratory results are not related to an infections at 
another site; and common skin commensal is cultured from 
two or more blood cultures drawn on separate occasions.
 
Proteus mirabilis √ √
Group B streptococcus √
Pseudomonas putida √
Enterobacter cloacae √ √
Citrobacter freundii √
Extended Spectrum Beta Lactamase
Klebsiella pneumoniae
√ √
Escherichia coli √ √ √ √
Streptococcus viridans √
Enterobacter agglomerans √
Enterobacter aerogenes √
